N.J. U.S. Attorney: New Jersey Laboratory and Owner/CEO Agree to Pay $13M to Settle Allegations of Kickbacks and Unnecessary Testing
January 11, 2024
January 11, 2024
NEWARK, New Jersey, Jan. 11 -- The office of the U.S. Attorney for the District of New Jersey issued the following news release on Jan. 10, 2024:
A clinical laboratory and its owner and chief executive officer have agreed to pay $13.25 million to resolve False Claims Act allegations involving illegal kickbacks and medically unnecessary laboratory testing, U.S. Attorney Philip R. Sellinger announced today.
RDx Bioscience Inc. (RDx), of Kenilworth, New Jersey, and its own . . .
A clinical laboratory and its owner and chief executive officer have agreed to pay $13.25 million to resolve False Claims Act allegations involving illegal kickbacks and medically unnecessary laboratory testing, U.S. Attorney Philip R. Sellinger announced today.
RDx Bioscience Inc. (RDx), of Kenilworth, New Jersey, and its own . . .